Clinical Trial Update: Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating sugammadex in high-risk ambulatory surgeries was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ambulatory Difficulties

Drugs mentioned

• Sugammadex (sugammadex)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Ambulatory Difficulty | Phase 4 | Status: WITHDRAWN